Generic drugs approved by FDA (through September 2008) including nisoldipine extended-release tablets and divalproex delayed-release tablets
Nisoldipine extended-release tablets, 20, 30, and 40 mg (equiv to Sular ER tablets) MYLAN
Divalproex delayed-release tablets, 125, 250, and 500 mg (equiv to Depakote delayed-release tablets) DR. REDDY'S, GENPHARM, LUPIN, NU-PHARM, SANDOZ, SUN, TEVA, UPSHER-SMITH
FDA Issues Complete Response Letter for Pz-Cel to Treat Epidermolysis Bullosa
April 22nd 2024Prademagene zamikeracel is a cell therapy designed to incorporate the functional collagen-producing COL7A1 gene into a patient’s own skin cells. The FDA is asking for additional information on manufacturing practices.